DOI QR코드

DOI QR Code

DH332, a Synthetic β-Carboline Alkaloid, Inhibits B Cell Lymphoma Growth by Activation of the Caspase Family

  • Gao, Pan (Research Center for Immunology, Xinxiang Medical University, East of JinSui Road of XinXiang City) ;
  • Tao, Ning (Protein & Peptide Pharmaceutical Laboratory, Institute of Biophysics, Chinese Academy of Sciences) ;
  • Ma, Qin (Xinjiang Huashidan Pharmaceutical Co. Ltd.) ;
  • Fan, Wen-Xi (Xinjiang Huashidan Pharmaceutical Co. Ltd.) ;
  • Ni, Chen (Protein & Peptide Pharmaceutical Laboratory, Institute of Biophysics, Chinese Academy of Sciences) ;
  • Wang, Hui (Research Center for Immunology, Xinxiang Medical University, East of JinSui Road of XinXiang City) ;
  • Qin, Zhi-Hai (Protein & Peptide Pharmaceutical Laboratory, Institute of Biophysics, Chinese Academy of Sciences)
  • 발행 : 2014.05.15

초록

Aim: The purpose of this study was to investigate anti-tumor effects and safety of DH332, a new ${\beta}$-carboline alkaloids derivatives in vitro and in vivo. Materials and Methods: The effects of DH332 on human (RAMOS RA.1) and mouse (J558) B lymphoma cell lines were detected using a CCK-8 kit (Cell Counting Kit-8), and apoptosis was detected by flow cytometry with PI/annexinV staining. Western blotting was used to detected caspase-3 and caspase-8. Neurotoxic and anti-tumor effects were evaluated in animal experiments. Results: DH332 exerts a lower neurotoxicity compared with harmine. It also possesses strong antitumor effects against two B cell lymphoma cell lines with low $IC_{50s}$. Moreover, DH332 could inhibit the proliferation and induce the apoptosis of RAMOS RA.1 and J558 cell lines in a dose-dependent manner. Our results suggest that DH332 triggers apoptosis by mainly activating the caspase signaling pathway. In vivo studies of tumor-bearing BALB/c mice showed that DH332 significantly inhibited growth of J558 xenograft tumors. Conclusions: DH332 exerts effective antitumor activity in vitro and in vivo, and has the potential to be a promising drug candidate for lymphoma therapy.

키워드

참고문헌

  1. Ahmed A, Taylor N (1959). The analysis of drug-induced tremor in mice. Br J Pharmacol Chemother, 14, 350-4. https://doi.org/10.1111/j.1476-5381.1959.tb00255.x
  2. Aricioglu F, Yillar O, Korcegez E, Berkman K (2003). Effect of harmane on the convulsive threshold in epilepsy models in mice. Ann N Y Acad Sci, 1009, 190-5. https://doi.org/10.1196/annals.1304.023
  3. Asgarpanah J, Ramezanloo F (2012). Chemistry, pharmacology and medicinal properties of peganum harmala l. J Pharm Pharmacol, 6, 1573-80.
  4. Bourke C, Carrigan M, Dixon R (1990). Upper motor neurone effects in sheep of some beta carboline alkaloids identified in zygophyllaceous plants. Aust Vet J, 67, 248-51. https://doi.org/10.1111/j.1751-0813.1990.tb07778.x
  5. Chen Q, Chao R, Chen H, et al (2005). Antitumor and neurotoxic effects of novel harmine derivatives and structure-activity relationship analysis. Int J Cancer, 114, 675-82 . https://doi.org/10.1002/ijc.20703
  6. Chen Z, Schell J, Ho C, Chen K (1998). Green tea epigallocatechin gallate shows a pronounced growth inhibitory effect on cancerous cells but not on their normal counterparts. Cancer Lett, 129, 173-9. https://doi.org/10.1016/S0304-3835(98)00108-6
  7. Dai F, Chen Y, Song Y, et al (2012). A natural small molecule harmine inhibits angiogenesis and suppresses tumour growth through activation of p53 in endothelial cells. PLoS One, 7, 52162. https://doi.org/10.1371/journal.pone.0052162
  8. Faustman D, Davis M (2010). TNF receptor 2 pathway: Drug target for autoimmune diseases. Nat Rev Drug Discov, 9, 482-93. https://doi.org/10.1038/nrd3030
  9. Khan F, Maalik A, Iqbal Z, Malik I (2013). Recent pharmacological developments in beta-carboline alkaloid "harmaline". Eur J Pharmacol, 721, 391-4. https://doi.org/10.1016/j.ejphar.2013.05.003
  10. Li P, Li Y, Liu B, et al (2014). Curcumin inhibits MHCC97H liver cancer cells by activating ROS/TLR-4/Caspase signaling pathway. Asian Pac J Cancer Prev, 15, 2329-34 https://doi.org/10.7314/APJCP.2014.15.5.2329
  11. Reus G, Stringari R, Souza, B, et al (2010). Harmine and imipramine promote antioxidant activities in prefrontal cortex and hippocampus. Oxid Med Cell Longev, 3, 325-31. https://doi.org/10.4161/oxim.3.5.13109
  12. Reniers J, Robert S, Frederick R, et al (2011). Synthesis and evaluation of beta-carboline derivatives as potential monoamine oxidase inhibitors. Bioorg Med Chem, 19, 134-44. https://doi.org/10.1016/j.bmc.2010.11.041
  13. Saano V, Airaksinen M (1982). Binding of $\beta$-carbolines and caffeine on benzodiazepine receptors: Correlations to convulsions and tremor. Acta Pharmacol Toxicol, 51, 300-8.
  14. Sehitoglu M, Farooqi A, Qureshi M, Butt G, Aras A (2014). Anthocynins: targeting of signaling networks in cancer cells. Asian Pac J Cancer Prev, 15, 2379-81. https://doi.org/10.7314/APJCP.2014.15.5.2379
  15. Sekaran S, Leow S, Abobaker N, et al (2010). Effects of oil palm phenolics on tumor cells in vitro and in vivo. J Food Sci, 4, 495-502.
  16. Yang X, Wang W, Qin J, et al (2012). JKA97, a novel benzylidene analog of harmine, exerts anti-cancer effects by inducing g1 arrest, apoptosis, and p53-independent up-regulation of p21. PloS one, 7, 34303. https://doi.org/10.1371/journal.pone.0034303
  17. Yonezawa T, Hasegawa S, Asai M, et al (2011). Harmine, a beta-carboline alkaloid, inhibits osteoclast differentiation and bone resorption in vitro and in vivo. Eur J Pharmacol, 650, 511-8. https://doi.org/10.1016/j.ejphar.2010.10.048
  18. Yonezawa T, Lee J, Hibino A, et al (2011). Harmine promotes osteoblast differentiation through bone morphogenetic protein signaling. Biochem Biophys Res Commun, 409, 260-5. https://doi.org/10.1016/j.bbrc.2011.05.001
  19. Zeng Y, Zhang Y, Weng Q, Hu M, Zhong G (2010). Cytotoxic and insecticidal activities of derivatives of harmine, a natural insecticidal component isolated from Peganum harmala. Molecules, 15, 7775-91. https://doi.org/10.3390/molecules15117775